fbpx

QQQ
+ 0.35
372.63
+ 0.09%
BTC/USD
+ 1369.93
44180.50
+ 3.2%
DIA
+ 0.36
347.20
+ 0.1%
SPY
+ 0.78
442.40
+ 0.18%
TLT
-1.45
149.81
-0.98%
GLD
-0.19
163.70
-0.12%

What 18 Analyst Ratings Have To Say About Biogen

July 16, 2021 2:50 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings:

Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago
Bullish 0 0 4 0
Somewhat Bullish 1 1 4 1
Indifferent 0 1 5 0
Somewhat Bearish 0 0 0 0
Bearish 0 0 0 0

In the last 3 months, 18 analysts have offered 12-month price targets for Biogen. The company has an average price target of $428.61 with a high of $647.00 and a low of $245.00.

price target chart

This current average represents a 30.67% increase from the previous average price target of $328.0.

How Are Analyst Ratings Determined?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish “analyst ratings” for stocks. Analysts typically rate each stock once per quarter.

Analysts can recommend “buy”, “sell”, “hold”, or similar verbage for each stock based on that company’s recent performance. “Buy” indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and is a recommendation to purchase the stock. On the other hand, “Sell” implies that an analyst forecasts a downwards trend for the stock. “Hold” suggests that investors should maintain their positions on that stock because of forecasted stagnation or lack of new information.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Analyst Ratings

Related Articles

Where Biogen Stands With Analysts

Where Biogen Stands With Analysts

Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings: read more
Expert Ratings For Biogen

Expert Ratings For Biogen

Over the past 3 months, 7 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. read more
Expert Ratings For Biogen

Expert Ratings For Biogen

Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) within the last quarter: read more

Expert Ratings For Biogen

Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago read more